The third Population-based HIV Impact Assessment (PHIA) survey in Eswatini, named SHIMS 3, showed the remarkable progress the southern African nation has made in addressing the HIV epidemic – demonstrating a major reduction in new HIV infections over the last decade....
In Eswatini, ICAP at Columbia University, in partnership with the Ministry of Health (MOH) and other collaborators, has successfully enrolled 1,400 participants in a study assessing human papillomavirus (HPV) vaccine regimens for children, adolescents, and young women...
For the first time, the U.S. Food and Drug Administration (FDA) has approved a long-acting injectable agent for the prevention of HIV, an alternative to daily pills for HIV prevention and an important step forward in the quest for global HIV epidemic control. ICAP at...
